๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A pilot study of high-dose domperidone as an antiemetic in patients treated with cisplatin

โœ Scribed by Tonato, M.; Roila, F.; Del Favero, A.; Tognoni, G.; Franzosi, M.G.; Pampallona, S.


Book ID
122299517
Publisher
Elsevier Science
Year
1985
Weight
388 KB
Volume
21
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A dose-finding study of granisetron, a n
โœ M. Soukop ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 663 KB

In this double-blind study, the efficacy and safety of a single intravenous dose of a novel antiemetic, granisetron, was assessed at two dose levels (40 ~g/kg and 160 Ixg/kg). A group of 355 patients were given prophylactic granisetron prior to receiving highdose cisplatin chemotherapy. In the first

A phase II study of ondansetron as antie
โœ V. Barbounis; G. Koumakis; M. Vassilomanolakis; H. Hatzichristou; S. Tsousis; A. ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 651 KB

The field of high-dose chemotherapy with stem cell transplantation has been expanded recently as a treatment for solid tumors and hematological malignancies. Severe emesis remains one of the main extramedullary side-effects of high-dose regimens during the first week of treatment. Traditional antiem

A randomized, double-blind comparison of
โœ Suzanne H. Stephens; V. Lee Silvey; Richard H. Wheeler ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 414 KB ๐Ÿ‘ 2 views

Thirty-seven patients with advanced incurable malignancies who were receiving their first course of cisplatin (2 90 mg/mz bolus), alone or in combination with other antineoplastic agents, were entered in this randomized, double-blind study to determine the antiemetic efficacy of the addition of high